A3P 2024 Congress
EU GMP Annex 1 / Patient risk management ICH Q9(R1) / Digitalization
Venue
Espace Bellevue, Biarritz (France)
Format
Conferences, workshops, exhibition
Share
The 35th edition of the A3P 2024 Annual International Congress will take place on October 8, 9 and 10, 2024. Like every year, it brings together the entire profession to discuss the major challenges facing the pharmaceutical industry.
This year’s program is based on Annex 1 feedback, patient risk management according to ICH Q9(R1) and digitalization. It features conferences with the participation of health authorities, workshops, as well as an exhibition with over 120 exhibitors.
Once again this year, the 3-day event will provide a major forum for exchanges and opportunities to strengthen relationships between pharmaceutical industry experts.
We look forward to welcoming you, to share with you these moments of technical and scientific discussion and exchanges that are always highly professional, in a convivial atmosphere that is year after year the hallmark of the event and its reputation.
Official conference language : French
Simultaneous translation of conferences : French <-> English
Simultaneous translation of conferences : French <-> English
Tuesday, October 08th
Welcome of the participants
08:00
A word from the president
Jacques NAVELLOU - A3P
08:50
Introductory conference - Integrating environmental issues into the pharmaceutical industry
Julien TRIQUET - CSL BEHRING & Samah RINGA - VEOLIA & Antoine TOUSSAINT - GSK
09:00
Introduction to the "Digitalization" session
Jean-Louis JOUVE - COETIC
09:25
"Factory of the Future": from strategy to execution
Pierre DORIGNAUX - TAKEDA
09:30
Digital transformation, driving simplification in the control laboratory
Olivier ANTOINE & Helene LAGNEAUX - SANOFI EVF
10:00
Coffee break on the exhibition
10:30
Good Manufacturing Practices supported by digital transformation - Feedback
Vincent BIGEARD & Xavier NOLLEVEAUX - VIRBAC
11:30
Digitalization modeling of aeraulic flow in design phases and benchmark 
Rodolphe HENRIETTE - NOVO NORDISK
11:50
Optimizing Bioprocess Development with Informed Multi-Step Design of Experiment
Julien DE CROM - UCB & Thomas CORNET - DNALYTICS
12:10
Q&A session
Vincent BIGEARD & Xavier NOLLEVEAUX - VIRBAC / Rodolphe HENRIETTE - NOVO NORDISK / Julien DE CROM - UCB & Thomas CORNET - DNALYTICS
12:30
Lunch at the Casino
13:00
Introduction to the "ICH Q9(R1) Patient Risk Management" session
Christophe MEUNIER - AKTEHOM & Anne HAYS - EBI
14:55
ICH Q9(R1) Implementation Quality Risk Management
Jean-François DULIERE - ISPE
15:00
Veterinary drug inspection and risk management
Maryline BUGGIN-DAUBIE - ANSES / ANMV
15:30
Coffee break on the exhibition
16:00
A look back on the "ICH Q9(R1) Experience: where are we now?" survey
Christophe MEUNIER - AKTEHOM & Anne HAYS - EBI
17:00
Challenges and benefits of risk based approaches for standardization and simplification
Cécile FEUILLET - SANOFI
17:30
How can risk management be adapted to the technical and human environment? Specific work needs to be done to manage and control subjectivity
Sonia LASSURE - SERVIER & Camille LANDRIEU - AKTEHOM
18:00
Cocktail on the exhibition
18:30
Wednesday, October 09th
A3P Human Breakfast "Emergency and Humanity: «TULIPE» - The Donation of Medicines at the Heart of Humanitarian Crises" at Casino Municipal
Join us for an exceptional interactive breakfast with A3P HUMAN, where we will explore how solidarity and humanitarian action give deep meaning to pharmaceutical projects. Find out more about the TULIPE association - a remarkable pharmaceutical industry emergency transfer project - which responds to global health crises with efficiency and humanity.
Our guests, Alexandre Laridan, TULIPE's Director of Operations, and Anne Carpentier, the association's Head Pharmacist, will share their experiences and challenges in the rapid distribution of medicines to crisis zones such as Ukraine, Gaza and Chad. Together, we will discuss the added value for participating companies, the rigorous selection of partner NGOs, and TULIPE's future prospects, including the innovation of new health kits and the organisation of volunteer days.
This interactive conference will be a unique opportunity to hear inspiring testimonials on the real impact of solidarity and humanitarian aid, to understand the logistical and regulatory challenges, and to discover how everyone can contribute to these philanthropic actions. Don't miss this opportunity to find out more about their projects, which are making a significant difference to the lives of patients around the world.
Our guests, Alexandre Laridan, TULIPE's Director of Operations, and Anne Carpentier, the association's Head Pharmacist, will share their experiences and challenges in the rapid distribution of medicines to crisis zones such as Ukraine, Gaza and Chad. Together, we will discuss the added value for participating companies, the rigorous selection of partner NGOs, and TULIPE's future prospects, including the innovation of new health kits and the organisation of volunteer days.
This interactive conference will be a unique opportunity to hear inspiring testimonials on the real impact of solidarity and humanitarian aid, to understand the logistical and regulatory challenges, and to discover how everyone can contribute to these philanthropic actions. Don't miss this opportunity to find out more about their projects, which are making a significant difference to the lives of patients around the world.
07:30
Break
08:30
Beginning of the workshops at Espace Bellevue & Casino Municipal
The aim of the workshops is to raise awareness or to deepen theoretical or practical notions with the help of case studies that the participants must deal with during a workshop in order to propose solutions in the form of conclusions, written with the help of the expert facilitators. The workshop group is made up of an A3P manager (or moderator) from the Board of Directors, two facilitators chosen for their recognized skills (1 manufacturer and 1 supplier) and congress participants or exhibitors who have registered by name. During one day, the participants will exchange, work and debate around a technical or regulatory theme. Registering for the Congress allows you to participate in one of the 19 workshops that will be presented this year (subject to availability)
09:30
Coffee break on the exhibition
10:30
Continuation of the first part of the workshop
11:30
Lunch cocktail in the exhibition
12:30
Second part of the workshop
14:00
Coffee break on the exhibition
16:00
Continuation of the second part of the workshop
End around 18h
16:30
Gala Dinner
Formal wear required.
20:00
Thursday, October 10th
Welcome of the participants
07:30
Introduction to the "EU Annex 1" session
Julien TRIQUET - CSL BEHRING
08:25
Introduction: EU Annex1 in the regulatory environment: positioning and perspectives of various health authorities
Antoine AKAR - HUMANIM LIFE SCIENCES et Eric HURTUBISE - V3IE
08:30
Reflections and tools for implementing a APS strategy
Benoit FRANQUIN - CSL BEHRING & Jérôme WEISZ - NOVO NORDISK
09:00
ANSM : Key points about APS / CSS implementation and Working Height
Lu-Jie FERRE - ANSM
09:30
Coffee break on the exhibition
10:30
From proof of the absence of residual air in steam processes to the bio-decontamination of isolators and RABS by gaseous hydrogen peroxide (VH2O2) processes
Emna SLAMA - SYNEXIN & Dominique WEILL - DOWELI
11:15
What are the challenges facing the industry in the face of the new Annex 1 requirements for the lyophilization process?
Benoit MOREAU - GSK & Dominique SIERAKOWSKI - DS ASEPTIC COMPLIANCE
11:45
Continuous particulate monitoring in compliance to Annex 1 - Rethinking and consolidating fundamentals from design to operation
Béatrice FOURNIE - ASPEN NOTRE DAME DE BONDEVILLE & Thomas PEREZ - SANOFI
12:15
Closing of the 2024 Congress and lunch at the Casino
12:45
What is a “Workshop” at the A3P International Congress?
- Over the course of a day, participants exchange ideas, work and debate on a technical or regulatory theme presented by facilitators.
- The aim of the workshops is to raise awareness and explore theoretical or practical concepts in greater depth, using case studies that participants must deal with in sub-groups, in order to propose solutions in the form of conclusions, drawn up with the help of the expert facilitators.
- The workshop group is made up of an A3P representative (or moderator) from the A3P board, two facilitators chosen for their recognized skills, and participants (industrialists and suppliers) who register by name.
- Registration for the A3P 2024 Congress entitles you to take part in one of the 19 workshops to be presented this year (subject to availability).
- The list of workshops is available below. Click on the workshop title to find out more about its content.
Implementing an APS strategy: Focus on the Intervention & Operator Qualification Strategy (Annex 1)
Facilitators : Jérôme WEISZ - NOVO NORDISK & Lucile LIEGARD
Moderator : Pierre DEVAUX - THERAXEL
Implementing a PSA strategy: yes, but in concrete terms, HOW? A multitude of parameters need to be taken into account when drawing up an APS strategy, and the sum of all these parameters can make this strategy complex to manage on a routine basis. By concentrating on two parameters, namely the interventions to be simulated and personnel empowerment, the aim of this workshop is to propose a simple, pragmatic strategy, easily applicable by all industrialists and meeting all regulatory requirements. Come and play an active part in drawing up a proposed strategy, developing a risk analysis tool for interventions, and making it possible to merge process APSs and personal APSs. Translated with DeepL.com (free version)
Workshop 1
Implementing an APS strategy: Focus on the Campaign & Modifications & Shut-down Strategy (Annex 1)
Facilitators : Isabelle HOENEN - LILLY & Benoit FRANQUIN - CSL BEHRING
Moderator : Julien TRIQUET - CSL BEHRING
If you struggle with the interpretation of EU GMP Annex 1 expectations for the APS strategy to apply in case of filling campaign validation/revalidation and/or in case of modifications or shutdowns, this workshop will be a unique opportunity to learn and share rationales to comply with points 9.36 xii & xiii, 9.38 and 9.49 !
During this workshop, these expectations will be deeply assessed and discussed based on practical short case studies. Recommendations and risk assessment elements will be shared for further enrichment.
Feel free to come with your examples/case studies !
During this workshop, these expectations will be deeply assessed and discussed based on practical short case studies. Recommendations and risk assessment elements will be shared for further enrichment.
Feel free to come with your examples/case studies !
Workshop 2
What are the operational responses to annex 1 requirements for the freeze-drying process?
Facilitators : Elodie DECONINCK - GSK & Dominique SIERAKOWSKI - DS ASEPTIC COMPLIANCE & Sylvain BATION - BIOMERIEUX
Moderator : Jean Louis BELMON - VIRBAC
Proposal of technical and/or organizational solutions to answer some requirements of Annex 1 using existing equipment
Workshop 3
Hot topics in Sterility Assurance & Contamination Control - Workshop full
Facilitators : Patrizia MUSCAS - LILLY & Walid EL AZAB - QP PRO SERVICES
Moderator : Sophie AMADIO - LILLY
This workshop will aim at bringing the participants to reflect, debate, share knowledge around the hot topics related to sterility assurance and contamination control for aseptic manufacturing.
This workshop is intended for everyone, intermediate to experienced level, and should allow participants to analyze and discuss the critical aspects of the aseptic process, to consider various cases in real situation.
Under realistic conditions, the workshop will lead the participants to consider the Annex 1 expectations, the interpretation from authorities and will provide suggestions and examples for a good control program.
This workshop is intended for everyone, intermediate to experienced level, and should allow participants to analyze and discuss the critical aspects of the aseptic process, to consider various cases in real situation.
Under realistic conditions, the workshop will lead the participants to consider the Annex 1 expectations, the interpretation from authorities and will provide suggestions and examples for a good control program.
Workshop 4
How to develop and optimize cleaning in place processes (CIP) and with utensil washers while taking into consideration economic and environmental issues and guaranteeing the cleaning quality ?
Facilitators : Elodie MERET - HTL BIOTECHNOLOGIE & Alexandra GELLEREAU - COPHACLEAN
Moderator : Yves MOINARD - HUMANIM LIFE SCIENCES >
In order to guarantee the effectiveness and efficiency of a cleaning process on the installations concerned, one of the first steps is process development. This step is essential in order to optimize the critical process parameters as accurately as possible, so as to guarantee the effectiveness and quality control of the cleaning process, while taking into account economic and environmental issues.
Another important objective of this development phase is to establish the impact of variations in critical parameters on cleaning efficiency. This output data will be used to guide the design of cleaning equipment and justify the associated qualification and validation effort.
Workshop 5
Decontamination of Barrier Technologies (Cleaning and Bio-Decontamination) : How to meet the Annex 1 Requirements about this topic and all associated points. Focus on chapter 4,5, 8 and 9 around this thematic - Workshop full
Facilitators : Gwendal LACROIX - YPOSKESI & Elodie PASTRE - THERAXEL
Moderator : Christophe EMONARD - BIOMERIEUX
Management of direct and indirect product contact parts and especially in link with difficulty of dismantling for some of them batch to batch or campaign to campaign. From the operational methods to the validation phases. In association with a site producing Biological Sterile Drugs, this workshop will allow us to discuss about Cross Contamination, Biological and Environmental Contamination.
Workshop 6
The biofilm bane of water for pharmaceutical use Design, preventive and curative of pharmaceutical water production and distribution systems to avoid biofilms.
Facilitators : Aurélien PERIQUET - MERCK & Frédéric MONNIER - VEOLIA
Moderator : Hervé TASSERY - 5M PARTNER
Biolfilm is the bane of pharmaceutical water users. During this workshop we will explore:
- Sanitary design (stainless steel, minimum speed, Reynolds, loop design, etc.).
- Preventive management (recording and interpretation of critical parameters, monitoring, disinfection, maintenance, etc.)
- Curative management: what treatment, when to trigger it, etc.
Workshop 7
"Mastering Transformation: The Keys to Overcoming Resistance and Guiding Innovation in Your Professional Projects." - Workshop full
Facilitators : Dominique BEN DHAOU - POINT NORTH & Nicolas QUOEX - SKILLSPOTTING
Moderator : Anne HAYS - EBI
Our organizations are part of an environment that is changing more and more rapidly, which implies knowing how to reinvent ourselves and support the change that has become our daily life. Thus, it becomes critical to understand the issues associated with change as well as to equip oneself to overcome resistance within teams that constitute a major risk. Whether you are a manager, a project manager or simply an expert, this workshop will provide you with the keys to understanding as well as concrete tools and models to guide you in this exciting adventure by allowing you to become an effective agent of change!
Workshop 8
No problem = no improvement. Lean tools, the Lean mindset, and concrete solutions to boost performance. - Workshop full
Facilitators : Ronan LE FLOC'H – SANOFI & Vincent PHILIBERT - QP PHARMA
Moderator : Christophe MEUNIER - AKTEHOM
LEAN Management or the Joy of Solving Problems TOGETHER. The LEAN management approach, including its principles, mindset, methodologies, tools, and the tangible benefits will be presented, shared, and illustrated through your own situations. No results without joy: this workshop will give you the pleasure of learning and understanding TOGETHER why and how LEAN Management will help you improve your expected performance. To incorporate feedback from the past four years for improvement, the content will be organized as follows:
Content:
Specific features of this workshop:
Content:
- 1. Introduction / Roundtable ==> sharing among trainees
- 2. Theoretical contributions illustrated by practical and varied feedback
- Feedback from facilitators and participants on operational field experiences
- 3. Application via a serious game - experimenting with performance improvements
- Technical, organizational, methodological
- 4. Consolidation of lessons learned from the exercise through a focused sequence on the mindset, methodology, and especially the Lean tools
- Making learners aware of the exercise's teachings
- Transposing the key points into a takeaway memo
Specific features of this workshop:
- Serious game
- Participants' contributions prepared in advance
- Memo summarizing key points for effective practice upon return to their company
Workshop 9
Control data integrity by boosting team training and optimizing the risk management strategy for data and computerized systems.- Workshop full
Facilitators : Aurélien DUJARDIN – ASPEN & Antoine VINAULT - SANOFI
Moderator : Jean-Louis JOUVE - COETIC
Mastering data integrity requires collective awareness and a sound risk management strategy. The aim of this workshop is to provide practical, fun training on the theme of data integrity, to develop a culture of data integrity, and to co-construct an effective, robust data remediation and risk management strategy that guides you in the priorities and levers to implement.
Workshop 10
Optimize Digital Strategy of our (bio)pharmaceutical sites with the BioPhorum Digital Plant Maturity Model: Practical Case Study - Workshop full
Facilitators : Karine PERON - MERCK GROUP - LIFE SCIENCE & Yves BERTHOUZOZ - MERCK GROUP - HEALTHCARE
Moderator : Christophe BENOIT - ROMMELAG
This interactive session provides a unique opportunity for professionals in the pharmaceutical and biopharmaceutical industry to explore the digitalization of (bio)production facilities. It emphasizes the use of the 'Digital Plant Maturity Model' developed by the international working group of the BioPhorum, which Merck belongs to. It incorporates the latest technological references such as AI, as well as the latest operational imperatives (sustainability, EHS, cybersecurity...)
Workshop 11
From analytical risk to patient risk - Workshop full
Facilitators : Marc François-HEUDE – SANOFI & Gérald DE FONTENAY - CEBIPHAR
Moderator : Eric PETAT - ACM PHARMA
Demonstrating the quality of a pharmaceutical product involves analyzing it. With each analysis, the result is subject to an uncertainty which is not always well known or controlled. This uncertainty can lead to OOS results for a compliant batch, but also to erroneous acceptance of a non-compliant batch. Controlling patient risk therefore involves controlling the risks associated with the analytical process. The aim of this workshop is to identify these risks and provide tools for managing them, throughout the life cycle of the product and the analytical procedure.
Workshop 12
ICH Q9 R1 Quality Risk Management. Points identified as needing improvement EWG ICH Q9 - Workshop full
Animateurs : Jean-François DULIERE – ISPE & Maria AMAYA - GENENTECH
Modérateur : Frédéric BAR - STERIS
This workshop wil cover major changes in the R1.
Hazard Identification
Formality
Subjectivity
Risk Based decsion making
This will be supported as by cultural excellence.
Hazard Identification
Formality
Subjectivity
Risk Based decsion making
This will be supported as by cultural excellence.
Workshop 13
Investigation of actual or suspected microbiological non-conformities in pharmaceutical production - Workshop full
Facilitators : Thierry BONNEVAY - SANOFI & Arnaud CARLOTTI - EUROFINS
Moderator : Eric PETAT - ACM PHARMA
Microbiological quality of pharmaceutical products is an essential component in the release of medicines. Microbiological analyses performed to ensure compliance with acceptance criteria are regulated and their results have great impact on the availability of drugs for patients. Any non-conformity is a significant event with multiple consequences: batch rejection (availability of the drug, costs), probable widespread impact (production capacity, costs), delicate investigation (time, costs), and a point of interest/concern for several years. It is therefore important to be certain that the problem exists, and if so, to identify its source and cause.
Following a presentation of the general principles that guide the conduct of investigations, participants will study three cases of proven or suspected microbiological non-compliance and the means of investigation available to us to document them in a robust and scientific manner. It will be necessary to define their exact status (proven/unproven), to explain the source, the cause and their impact in order to implement the appropriate corrective and preventive actions where necessary. In particular, we will consider the case of a "non-compliant BioBurden" analysis, a case of a possibly non-compliant PSA and finally a case of a possibly non-compliant sterility test, taken from real industrial situations. The aim will be to identify appropriate strategies for these three types of case and to develop a relevant approach to investigating OOS in microbiology.
Following a presentation of the general principles that guide the conduct of investigations, participants will study three cases of proven or suspected microbiological non-compliance and the means of investigation available to us to document them in a robust and scientific manner. It will be necessary to define their exact status (proven/unproven), to explain the source, the cause and their impact in order to implement the appropriate corrective and preventive actions where necessary. In particular, we will consider the case of a "non-compliant BioBurden" analysis, a case of a possibly non-compliant PSA and finally a case of a possibly non-compliant sterility test, taken from real industrial situations. The aim will be to identify appropriate strategies for these three types of case and to develop a relevant approach to investigating OOS in microbiology.
Workshop 14
Towards a Sustainable Pharmaceutical Industry: Decarbonization, energy savings and much more ...
Facilitators : Michael FORMET - VETOQUINOL & Samah RINGA - VEOLIA
Dive into the environmental challenges of the pharma industry and leave with concrete solutions! On the agenda: Analysis of impacts and regulations. Real-world case studies: carbon footprint, energy efficiency, ... Brainstorming on energy-saving and decarbonization solutions Dynamic exchange of experiences and best practices Interactive workshops to develop your own strategies Practical toolkit to apply as soon as you return Fun and bilingual approach (FR/EN) for an enriching and stimulating day. Open to all levels eager to shape the sustainable future of our industry. Register now and become an agent of change!
Workshop 15
Student workshop: A day of immersion in the pharmaceutical industry: the environment and ZACs, PPI water and filtration, production and pharmaceutical formatting, quality control and regulations.
Facilitators : Benedicte GAS - CHARLES RIVER LABORATORIES & Gwenaelle CLECH - 5M PARTNER & Mats MICKOS - PHARMTEC & Francois MOREL - CABINET MOREL & Delphine BOIVIN - A3P ASSOCIATION
Moderator : Jonnathan TAFFORIN - A3P ASSOCIATION
The aim of this workshop is to take a closer look at fundamental aspects of the pharmaceutical industry that are essential for future managers or practicing executives, and to exchange ideas with exhibitors on stands that will illustrate the presentations made.
Four themes will be addressed during the day:
Four themes will be addressed during the day:
- Air: filtration, cleanrooms, airborne disinfection, clothing
- Liquids: water production and distribution, filtration and SUS (Single-Use Systems)
- Production equipment: filling lines, isolator and RABS (Restricted Access Barrier System), autoclave
- Quality: laboratory equipment, Qualification/Validation, services and consulting
Workshop 16
HVAC in controlled atmosphere zones (CAZ)
Facilitators : Patrice DAUDE - CATALENT & Cédric DESARMENIEN - LAPORTE EURO
Moderator : Anne CASSART - JANSEN CLEANROOMS & LABS
Review of the basic principles of air handling in controlled-atmosphere zones under the following headings:
Objectives of air handling in CAZs
Principles of air handling system design
Class, pressure and temperature zoning
Heat and air balance
Creation of a PID
Equipment definition
Integrating energy savings into ZAC design
Roles and objectives of digitizing an air handling system (Automation, BMS, remote supervision, Smart System, associated maintenance, etc.)
Conclusion on the links/correlation between digitizing HVAC systems and associated energy savings
Objectives of air handling in CAZs
Principles of air handling system design
Class, pressure and temperature zoning
Heat and air balance
Creation of a PID
Equipment definition
Integrating energy savings into ZAC design
Roles and objectives of digitizing an air handling system (Automation, BMS, remote supervision, Smart System, associated maintenance, etc.)
Conclusion on the links/correlation between digitizing HVAC systems and associated energy savings
Workshop 17
Retro QbD and CPV: how to manage your old products?
Facilitators : Alain NONN - ALPHA PHARMA CONSULTING & Stéphane VARLET - PROCTER & GAMBLE & Nathalie BRICARD - EXPLEO FRANCE
Moderator : Anne RIGOULOT - DELPHARM
Theoretical, entertaining and interactive presentations on the following topics by the presenters:
- Risk benefits: how to argue for a retro QbD approach? feedback
- Setting up QbD retro: What data do I need? How can it be used?
- Steps to follow, Pitfalls to avoid
- Continuous Process Verification (CPV)
- The aim of the workshop is to consider the various possible options, to select one for each group and to define the various stages, with their advantages and disadvantages, up to the implementation of the retro QbD.
Workshop 18
Development of an Integrated Container Closure Integrity Control Strategy - Workshop full
Facilitators : Henri HEBTING - LILLY & Matthias HIDDEMANN - WILCO
Moderator : Jacques NAVELLOU - AXYS NETWORK
Participants will learn from the speakers how to develop a holistic CCI control strategy based on the 2024 BioPhorum publication, and how to select appropriate testing methods at the different stages of a product life cycle. Within focus groups, participants will develop a CCI risk assessment for a new product, at different stages of the life cycle. They will be asked to identify potential risks and propose remediations via appropriate preventions and controls. There will be also hands-on experience with a show case CCI method.
Workshop 19
Exhibition Plan
Full exhibition
| Companies | n°stand |
| ABC TRANSFER | O14 |
| ADVANCED INSTRUMENTS | KO4 |
| AEROMETRIK | O6 |
| AKTEHOM | F19 |
| ALBHADES | R10BIS |
| AMSONIC – HAMO | R23 |
| ASEPTIC TECHNOLOGIES | K5 |
| ASSOCIATES OF CAPE COD | O36 / O37 |
| ATRYON | O13 |
| AVN | K2 |
| BATIMPRO CHARRIER | R12 |
| BAUSCH+STRÖBEL | R7 |
| BD | K16 |
| BECKMAN COULTER FRANCE | O22 |
| BIOMERIEUX | O43 / O44 |
| BIOPHARMA TECHNOLOGIES FRANCE | O38 |
| BWT | O42 |
| CAP INGELEC | K15 |
| CARSO LSEHL | R9 |
| CATALENT | B1 |
| CCIT | K6 |
| CHARGEPOINT TECHNOLOGY | O10 |
| CHARLES RIVER | R26 |
| CHRISTEYNS | F4 |
| CONFORMAT | O2 |
| CONTEC | O9 |
| COPHACLEAN | O48 |
| CYTIVA | O16 / O34 |
| DEVEA | R22 |
| ECOLAB | O32 / O33 |
| ELIS CLEANROOM | O24 / O26 |
| ELLAB FRANCE | K4 |
| ELSCOLAB | KO1 |
| ENDRESS+HAUSER | R30 |
| EREA PHARMA | R29 |
| EUROFINS BPT | F15 / F15BIS |
| GASPOROX | O11 |
| GETINGE FRANCE | B2 |
| GETINGE LA CALHENE | K19 |
| GIVE & TECH | O3 / O4 / O5 |
| GOMETROLOGIE | K14 |
| GROUPE ICARE | F12 |
| HEX + SAFYR | F1 |
| HOF SONDERANLAGENBAU | O50 |
| HONEYWELL – HPS | K17 |
| ILC DOVER | F10 |
| IMA FRANCE | F16 |
| INITIAL | O30 |
| INTERSCIENCE | O1 |
| INTERTEK FRANCE | O27 |
| IWT BY TECNIPLAST | O42BIS |
| JBT BOURSIER | O21 |
| JCE BIOTECHNOLOGY | O51 / O52 |
| KÖRBER PHARMA | O19 |
| LABORATOIRE HUCKERT’S INTERNATIONAL | R10 |
| LAPORTE EURO | R27 |
| LONZA COLOGNE | O45 |
| LSB – LA SALLE BLANCHE | R32 |
| MARCHESINI GROUP | F7 |
| MERCK | F13 / F14 |
| MESALABS | R4 |
| MGA TECHNOLOGIES | O28 |
| NEOCERAM | K8 |
| NIKKA DENSOK | KO3 |
| NOVATEK INTERNATIONAL | R20 |
| OPTIMA PHARMA | O46 |
| OXY’PHARM – SANIVAP | R25 |
| PARKER HANNIFIN | R5 |
| PARTICLE MEASURING SYSTEMS | K18 |
| PEMFLOW – TECHNOFILTRES | O41 |
| PFEIFFER VACUUM | O7 |
| PHARM-ALLIANCE | F6 |
| PHARM’ADIS | R21 |
| PHARMAPLAN | R24 |
| PHARMASEP | O47 |
| PHARMTEC | O17 |
| PIERCAN | R15 |
| PMT FRANCE | O23 |
| PQE GROUP | KO5 |
| PROMEPLA | K9 |
| PROSYS GROUP | B4 |
| RAUMEDIC | K7 |
| REALCO | R14 |
| ROMACO FRANCE | F11 |
| ROMMELAG | R8 |
| RT2i | K1 |
| SALAMANDERU | F9 |
| SCHOTT PHARMA | O20 |
| SCHREINER MEDIPHARM | O49 |
| SCHÜLKE FRANCE | O29 |
| SGD PHARMA | K12 |
| SGS HEALTH SCIENCE | R28 |
| SHERPAPHARMA | K3 |
| SIDJI | O8 |
| SKAN | F3 |
| SOFAST | F2 |
| SOLIDFOG TECHNOLOGIES | R31 |
| SOURCIN | O12 |
| SPC GROUP | K11 |
| STÄUBLI | O40 |
| STAXS | F8 |
| STERILINE | O18 |
| STERIS | R16 / R17 / R18 / R19 |
| SWAN | R3 |
| SYMBIOSE ENVIRONNEMENT | F17 / F18 |
| SYNEXIN | O25 / R1 |
| SYNTEGON TECHNOLOGY | O39 |
| TECHNIP ENERGIES | R6 |
| TECHNOCHIM | R13 |
| TEG | B3 |
| TELSTAR | O31 |
| TEMPRIS | KO2 |
| TERANGA GROUPE | O15 / O35 |
| TERUMO PHARMACEUTICALS | K10 |
| THERAXEL | R11 |
| VALTRIA | F5 |
| VEOLIA WATER TECHNOLOGIES | R2 |
| WARANET SOLUTIONS | K13 |
| WILCO | R7. |
Registration form
A3P International Congress
Once you have completed this form, you will receive a copy by email
✻
Registration fee :
Until September 8 : 1300€ excl. VAT (VAT 20%) + A3P Membership required (additional costs to be expected if you are not yet a member).
From September 9 : 1430€ excl. VAT (TVA 20%) + Membership required (additional costs to be expected if you are not yet a member).
To request a quote, please complete the form and select the “quote” option in the payment information section
To know if you are a member, please contact us.
To know the rates, please refer to the Membership section of the website : https://www.a3p.org/adhesion/
Contact
Depending on your requirements and preferences, please contact Natalina SEMEDO :
Phone : +33 (0)4 37 28 30 40
Email : nsemedo@a3pservices.com
Shuttles : Airport or SNCF station <-> Casino Bellevue
Shuttles will be available:
- Monday 7 October from 10:30 am to 11pm
- Tuesday 8 October from 9h30 am to 10:30 am
- Thursday 10 October from 9 am to 11 am and 12 am to 5 pm
No need to book, the shuttles make several round trips at these times.
Venue
Hotel reservations
The Tourisme Basque has blocked rooms in several of the city’s hotels especially for you, to ensure maximum availability and attractive rates.
Several types of hotels and budgets are available. You’ll find the list below.
Booking platform of Tourisme Basque : Click here
| Hôtels ** | |
| Hôtel Les Alizés | |
| Hôtels *** | |
| Hôtel Akena | Hôtel Oxo |
| Hôtels **** | |
| Hôtel Gran Tonic | Hôtel Florida |
| Hôtels ***** | |
| Hôtel Sofitel |
